De Novo AL Amyloidosis in Renal Allograft and Anti-CD38 Monoclonal Antibody Treatment

被引：1
|
作者：
Fotiou, Despina [1 ]
Skalioti, Chrysanthi [2 ]
Liapis, George [3 ]
Marinaki, Smaragdi [2 ]
Kastritis, Efstathios [1 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Laiko Hosp, Sch Med, Clin Nephrol & Renal Transplantat, Athens, Greece
[3] Natl & Kapodistrian Univ Athens, Laiko Hosp, Sch Med, Dept Pathol, Athens, Greece
来源：
HEMASPHERE | 2021年 / 5卷 / 12期
关键词：
DARATUMUMAB;
D O I：
10.1097/HS9.0000000000000665
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 50 条
  • [1] DARATUMUMAB Anti-CD38 Monoclonal Antibody, Treatment of Multiple Myeloma
    Richardson, P.
    Lokhorst, H.
    Palumbo, A.
    Nahi, H.
    Laubach, J.
    Gimsing, P.
    Lisby, S.
    Cakana, A.
    Brun, N. Constantin
    Plesner, T.
    DRUGS OF THE FUTURE, 2013, 38 (08) : 545 - 554
  • [2] CD38 and Anti-CD38 Monoclonal Antibodies in AL Amyloidosis: Targeting Plasma Cells and beyond
    Roccatello, Dario
    Fenoglio, Roberta
    Sciascia, Savino
    Naretto, Carla
    Rossi, Daniela
    Ferro, Michela
    Barreca, Antonella
    Malavasi, Fabio
    Baldovino, Simone
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (11) : 1 - 11
  • [3] A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia
    Chen, Yunfei
    Xu, Yanmei
    Li, Huiyuan
    Sun, Ting
    Cao, Xuan
    Wang, Yuhua
    Xue, Feng
    Liu, Wei
    Liu, Xiaofan
    Dong, Huan
    Fu, Rongfeng
    Dai, Xinyue
    Wang, Wentian
    Ma, Yueshen
    Song, Zhen
    Chi, Ying
    Ju, Mankai
    Gu, Wenjing
    Pei, Xiaolei
    Yang, Renchi
    Zhang, Lei
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (23) : 2178 - 2190
  • [4] Anti-CD38 antibody for refractory acquired hemophilia A
    Liu, Wei
    Liu, Jiaying
    Xue, Feng
    Yang, Renchi
    Zhang, Lei
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 21 (06) : 1515 - 1518
  • [5] Role of autologous haematopoietic cell transplantation in the treatment of systemic light chain amyloidosis in the era of anti-CD38 monoclonal antibodies
    Chakraborty, Rajshekhar
    Milani, Paolo
    Palladini, Giovanni
    Gertz, Morie
    LANCET HAEMATOLOGY, 2023, 10 (11): : E936 - E940
  • [6] Efficacy and mechanism of the anti-CD38 monoclonal antibody Daratumumab against primary effusion lymphoma
    Jutatip Panaampon
    Ryusho Kariya
    Seiji Okada
    Cancer Immunology, Immunotherapy, 2022, 71 : 1017 - 1031
  • [7] Efficacy and mechanism of the anti-CD38 monoclonal antibody Daratumumab against primary effusion lymphoma
    Panaampon, Jutatip
    Kariya, Ryusho
    Okada, Seiji
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (05) : 1017 - 1031
  • [8] Implications for the monitoring of patients with multiple myeloma undergoing treatment with the anti-CD38 monoclonal daratumumab
    Thirkettle, Sally
    Russell, Joanne
    Wilson, Sarah
    Ganijee, Tasneem
    Kulkarni, Samar
    Cavet, Jim
    Monaghan, Phillip J.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2020, 57 (02) : 178 - 181
  • [9] Anti-CD38 monoclonal antibody impairs CD34+mobilization and affects clonogenic potential in multiple myeloma patients
    Zappaterra, Arianna
    Civettini, Ivan
    Cafro, Anna Maria
    Pezzetti, Laura
    Pierini, Silvia
    Anghilieri, Michela
    Bellio, Laura
    Bertazzoni, Paola
    Grillo, Giovanni
    Minga, Periana
    Pioltelli, Maria L.
    Ravano, Emanuele
    Sassone, Marianna
    V. Vigano, Clara
    Volpato, Elisabetta B.
    Gambacorti-Passerini, Carlo
    Rossini, Silvano
    Cairoli, Roberto
    Crocchiolo, Roberto
    BLOOD TRANSFUSION, 2024, 22 (04) : 328 - 337
  • [10] Expert Consensus on the Incorporation of Anti-CD38 Monoclonal Antibody Therapy Into the Management of Newly Diagnosed Multiple Myeloma
    Lonial, Sagar
    Bowser, Andrew D.
    Chari, Ajai
    Costello, Caitlin
    Krishnan, Amrita
    Usmani, Saad Z.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (11) : 815 - 824
12345